MARKET

VTVT

VTVT

Vtv Therapeutics
NASDAQ
16.54
+0.22
+1.35%
Closed 16:00 12/04 EST
OPEN
16.19
PREV CLOSE
16.32
HIGH
17.38
LOW
16.18
VOLUME
100.82K
TURNOVER
--
52 WEEK HIGH
30.99
52 WEEK LOW
7.38
MARKET CAP
49.79M
P/E (TTM)
-3.7414
1D
5D
1M
3M
1Y
5Y
1D
vTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference
Barchart · 2d ago
Weekly Report: what happened at VTVT last week (1125-1129)?
Weekly Report · 2d ago
Weekly Report: what happened at VTVT last week (1118-1122)?
Weekly Report · 11/25 12:15
Weekly Report: what happened at VTVT last week (1111-1115)?
Weekly Report · 11/18 12:11
vTv Therapeutics GAAP EPS of -$0.88
Seeking Alpha · 11/13 07:10
vTv Therapeutics Q3 EPS $(0.88) Up From $(3.19) YoY
Benzinga · 11/12 22:14
*VTv Therapeutics 3Q Rev $0.00 >VTVT
Dow Jones · 11/12 22:07
*vTv Therapeutics 3Q Loss/Shr 88c >VTVT
Dow Jones · 11/12 21:05
More
About VTVT
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases. Its products pipeline includes TTP399, TTP273, HPP737 and HPP593. TTP399 is an orally administered, small molecule, liver-selective glucokinase activator (GKA) in development potential oral anti-diabetic for the treatment of type I diabetes. TTP399 completed the SimpliciT-I Study, a Phase II trial in patients with type I diabetes as an add-on to insulin therapy. Its HPP737 is an orally administered, non-central nervous system (CNS) penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases. TTP273 is an orally available, small molecule glucagon-like peptide 1 (GLP-1) receptor agonist, which is focused on treating postprandial hyperglycemia in cystic fibrosis related diabetes (CFRD) patients and cystic fibrosis patients. Its products pipeline also includes Azeliragon and HPP3033.

Webull offers vTv Therapeutics Inc stock information, including NASDAQ: VTVT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VTVT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VTVT stock methods without spending real money on the virtual paper trading platform.